MRT199665 is a ATP-Competitive MARK/SIK/AMPK Inhibitor
In acute myeloid leukemia (AML), chemotherapy resistance remains prevalent and poorly understood. AML are cancers of the blood. They originate in the hematopoietic progenitor cells as a result of the…